alert-icon
Er is beperkt informatie beschikbaar in de geselecteerde taal. Alle informatie is wel beschikbaar op de internationale website in het Engels.
  • Oplossingen
  • Carrières
  • Investeerders

Over Wolters Kluwer

Wolters Kluwer is een wereldwijd leverancier van professionele informatie, software-oplossingen en diensten voor artsen, verpleegkundigen, accountants, juristen en op het gebied van belasting, financiën, audit, risico, en regelgeving.

Over ons
  • Organisatie
  • Strategie
  • Over Wolters Kluwer
Kennis & Expertise
  • Alle expertise weergeven
  • Gezondheidszorg
  • Fiscaal & Accountancy
  • ESG
  • Financieel
  • Compliance
  • Juridisch
Krijg hulp
  • Contact
  • Login
  • eShop & Bookstores
  • Bekijk Solution List
  • Mediacenter
  • Nieuws & persberichten
  • Oplossingen
  • Carrières
  • Investeerders
PrimaryNav Button
Wolters Kluwer Logo
Zoeken
    No Suggestion
    WK logo

    Bezoek onze internationale site in het Engels, of selecteer hieronder een alternatieve locatie of taal

    • Noord- en Zuid-Amerika
    • Europa
    • Azië & Pacific
    Brazilië
    Startpagina:
    • Portugees
    Canada
    Startpagina:
    • Engels
    • Frans
    Latam
    Startpagina:
    • Spaans
    Verenigde Staten
    Startpagina:
    • Engels
    Huidige Pagina:
    • Engels
    België
    Startpagina:
    • Nederlands
    • Frans
    Tsjechië
    Startpagina:
    • Tsjechisch
    Danmark
    Startpagina:
    • Deens
    Frankrijk
    Startpagina:
    • Frans
    Duitsland
    Startpagina:
    • Duits
    Hongarije
    Startpagina:
    • Hongaars
    Italië
    Startpagina:
    • Italiaans
    Nederland
    Startpagina:
    • Nederlands
    Noorwegen
    Startpagina:
    • Noors
    Polen
    Startpagina:
    • Pools
    Portugal
    Startpagina:
    • Portugees
    Romania
    Startpagina:
    • Romanian
    Slowakije
    Startpagina:
    • Slowaaks
    Spanje
    Startpagina:
    • Spaans
    Zweden
    Startpagina:
    • Zweeds
    Verenigd Koninkrijk
    Startpagina:
    • Engels
    Australia
    Startpagina:
    • Engels
    China
    Startpagina:
    • Vereenvoudigd Chinees
    Hong Kong
    Startpagina:
    • Engels
    India
    Startpagina:
    • Engels
    Japan
    Startpagina:
    • Japans
    Maleisië
    Startpagina:
    • Engels
    Nieuw-Zeeland
    Startpagina:
    • Engels
    Philippines
    Startpagina:
    • Engels
    Singapore
    Startpagina:
    • Engels
    Zuid-Korea
    Startpagina:
    • Engels
    Taiwan
    Startpagina:
    • Engels
    Thailand
    Startpagina:
    • Engels
    Vietnam
    Startpagina:
    • Engels
    Primary Navigation
    • Gezondheidszorg

      Vertrouwde klinische technologie en oplossingen die zorgen voor effectieve en op bewijs gebaseerde besluitvorming en resultaten in de gezondheidszorg. Gespecialiseerd in klinische effectiviteit, leren, onderzoek en veiligheid.

      Meer info
      Oplossingen
      • UpToDateMarktleidende klinische besluitvormingsondersteuning
      • OvidHet meest vertrouwde medische onderzoeksplatform ter wereld
      • UpToDate LexidrugWetenschappelijk onderbouwde oplossingen voor geneesmiddelenreferenties
      • Ovid SynthesisWerkstroomoplossing voor de verbetering van klinische werkwijzen
      Alle oplossingen weergeven
      Kennis & Expertise
      • So wird Ihr Krankenhaus dank IT-Unterstützung hochgradig zuverlässig
      • Zorgprofessionals betrouwbare en uniforme oplossingen bieden voor ondersteuning bij klinische beslissingen (CDSS)
      Alle expertise weergeven
    • Fiscaal en Accountancy

      We helpen fiscalisten, accountants, boekhoudprofessionals en bedrijven efficiënter te werken, productiviteit te verhogen, nieuwe technologie in te zetten en betere resultaten te bereiken. Met onze expertise, intelligente software en eenvoudige workflow tools helpen wij organisaties bij het groeien, managen en beschermen van hun activiteiten én die van hun klanten.

      Meer info
      Oplossingen
      • Twinfield BoekhoudenOnline boekhouden voor ondernemers en accountants
      • BaseconeFactuurherkenning, factuurautorisatie
      • InView EssentialAlle relevante online vakinformatie per rechtsgebied gebundeld
      • InView TaxHet toekomstbestendige platform waar vakinformatie en technologie samenkomt
      Alle oplossingen weergeven
      Trends
      • Future Ready Accountant
      • Kunstmatige Intelligentie (AI) in boekhouding en belastingen
      Kennis & Expertise
      • De toekomst met InView Tax: slimmer, sneller en efficiënter
      • Meer ondersteuning voor de fiscale praktijk: InView Tax uitgebreid met Praktisch Pakket
      • Goederen importeren van buiten de EU
      • InView Tax: een nieuwe standaard voor fiscalisten
      Alle expertise weergeven
    • ESG

      Uitgebreide tools en deskundige begeleiding die bedrijven helpen te voldoen aan regelgeving bij duurzaamheidsinitiatieven en efficiënt om te gaan met risico’s op het gebied van ESG.

      Meer info
      Oplossingen
      • CCH TagetikGecentraliseerde prestatiebeheersoftware
      • OneSumX for Finance, Risk and Regulatory ReportingOntdek onze ESG-oplossing voor het omgaan met klimaatrisico's en regelgeving
      • TeamMateOplossingen voor auditors
      • EnablonSoftwareoplossingen op het gebied van risicobeheer en compliance, techniek en bedrijfsvoering en EHSQ en duurzaamheid
      Alle oplossingen weergeven
      Kennis & Expertise
      • Wolters Kluwer lanceert de Collectie ESG
      • De ESG-checklist van Wolters Kluwer: drie key takeaways
      • 6 signs you are ready for BowTieXP Enterprise
      • Het ABC van ESG-rapportages: Wat zijn ESG-rapportages en duurzaamheidsverslagen, waarom zijn ze belangrijk en wat moeten CFO's weten? 
      • ESG Onderzoeksrapport: De nieuwe spelregels van de CSRD
      • Software voor ESG- en duurzaamheidsrapportages
      Alle expertise weergeven
    • Financieel

      Onze oplossingen voor gereguleerde financiële afdelingen en instellingen helpen klanten aan hun verplichtingen te voldoen jegens externe toezichthouders. Wij zijn gespecialiseerd in het samenbrengen en optimaliseren van processen om een real-time en accurate weergave van uw financiële positie te leveren.

      Meer info
      Oplossingen
      • CCH TagetikUniforme software voor prestatiebeheer
      • OneSumX for Finance, Risk and Regulatory ReportingGeïntegreerd pakket aan oplossingen voor regelnaleving
      • BaseconeFactuurherkenning, factuurautorisatie
      Alle oplossingen weergeven
      Kennis & Expertise
      • Goederen importeren van buiten de EU
      • 7 tips om met je bedrijf het jaar goed te starten
      • Betere beslissingen dankzij op feiten gebaseerde besluitvorming
      • AI in Finance: Hoe balanceren CFO's teambehoeften, kansen en risico’s?
      • 5 btw-vragen over zakelijke kosten die aftrekbaar zijn en meer
      • Prinsjesdag: de nabeschouwing van fiscale mobiliteit
      • Prinsjesdag: alles over fiscale mobiliteit en fatbikes
      • De ESG-checklist van Wolters Kluwer: drie key takeaways
      Alle expertise weergeven
    • Compliance

      We stellen organisaties in staat naleving te waarborgen aan steeds veranderende wettelijke verplichtingen, risico’s te beheersen, de efficiëntie te verhogen en betere zakelijke resultaten te boeken.

      Meer info
      Oplossingen
      • Enablon Software voor operationeel risicomanagement
      • TeamMateInterne oplossing voor auditbeheer en -analyse die consistentie in de auditworkflow
      • OneSumX for Finance, Risk and Regulatory ReportingGeïntegreerd pakket aan oplossingen voor regelnaleving
      • LegiswayAlles-in-één-managementsysteem voor juridische afdelingen
      Alle oplossingen weergeven
      Kennis & Expertise
      • AI-governance in de juridische sector: van compliance-uitdaging naar strategische kans
      • Strategisch leiderschap als sleutel tot effectieve AI-adoptie
      • AI: altijd een middel, nooit het doel op zich
      • Balanceren tussen innovatie en betrouwbaarheid in juridische en fiscale AI-oplossingen
      • 10 tips voor het veilig omgaan met persoonlijke data
      • Kan generatieve AI voor de advocatuur méér worden dan een hulpmiddel voor routinewerk?
      • Navigator heet nu InView Essential
      • Innoveren op je 187e: hoe doe je dat?
      Alle expertise weergeven
    • Juridisch

      We helpen juridische professionals op advocatenkantoren, juridisch advieskantoren en juridische afdelingen van bedrijven met data-gedreven besluitvormingstools. Wij brengen  juridisch en regelgevingsonderzoek, analyse en workflows samen om waarde voor organisaties te creëren en te zorgen voor een meer transparante, rechtvaardige en veilige samenleving.

      Meer info
      Oplossingen
      • InView EssentialAlle relevante online vakinformatie per rechtsgebied gebundeld
      • InView LegalHet toekomstbestendige platform waar vakinformatie en technologie samenkomt
      • KleosDossierbeheer en praktijkmanagement software voor de advocatuur
      • LegiswayAlles-in-één-managementsysteem voor juridische afdelingen
      Alle oplossingen weergeven
      Kennis & Expertise
      • Outsourcing strategieën voor juridische teams in 2025
      • Kennis van Contract- & Entitetsbeheer in 2025
      • Goed tijdschrijven vraagt om goede software en gedisciplineerd gedrag
      • De toekomst met InView Tax: slimmer, sneller en efficiënter
      • Realisatiegraad van advocatenkantoren: controle over inkomsten & betalingen
      • Ali al Khatib: “De overheid in het gareel houden doe je ook vaak in bestuursrechtelijke context”
      • Meer ondersteuning voor de fiscale praktijk: InView Tax uitgebreid met Praktisch Pakket
      • InView Tax: een nieuwe standaard voor fiscalisten
      Alle expertise weergeven
    1. Terug naar Home >
    2. Terug naar Oplossingen >
    3. Terug naar Lippincott Journals >
    4. Terug naar Lippincott Open Access >
    5. Frequently asked questions

    Frequently Asked Questions About Open Access

    View some common questions about open access, the difference between that and free, what the Creative Commons License is, and much more.
    Secondary Navigation
    Lippincott Journals
    • Authors
    • Editor Resources
    • Editorial Supplements
    • Wolters Kluwer Open Access

      Open access is the free, immediate online access for any user to digital scientific and scholarly material, primarily research articles published in peer‐reviewed journals.

      Learn more
      Open Access
      • Overview
      • About Us
      • Publish
      • Partner
      • Funders and Institutions’ Mandates
      • Journals
      • Frequently Asked Questions
    • Society Services
    • News From Our Journals
    • Advertisers
    • Support
    Shop Our Journals
    • What is open access?

      The free, immediate, online access, for any user, web‐wide, to digital scientific and scholarly material, primarily research articles published in peer‐reviewed journals.

    • What is the hybrid model?

      The hybrid model is when a journal has a combination of open access and subscription articles. Authors have a choice to pay a fee for the article to be immediately accessible online. The author retains copyright of the article. Open Access articles are subject to the same peer review process as any article within that journal.

    • What is the gold model?

      The gold model refers to journals that are fully Open Access and no subscription is required to access them. All articles published in one of our gold open access journals are freely available to readers. There is no subscription fee to read and access content and articles are made available under the terms of a Creative Commons license. Most of our gold journals allow the authors to choose one of several CC licenses including CC BY.

    • Are the peer review and production processes the same for open access articles?

      Yes, the peer review and production processes are the same for the open access articles in the hybrid model as they are for those articles published and accessible by subscription or pay per view.

    • How does the journal ensure that the peer review process isn’t biased?

      All articles undergo the journal’s standard peer review process. Authors are given the option to make an article open access only after the article has been returned for revisions or accepted.

    • When will an author be given a choice to publish a paper open access?

      Authors will have the option to publish their paper as open access after the article has been sent back for revisions, and acceptance.

    • Who can request an article to be open access?

      Only the author of the manuscript can request an article to be open access. Funders of the published work may request open access with express written permission from the author.

    • How will I know if an article is open access?

      LWW articles that are open access have the open icon next to them.

    • Should authors still sign the Copyright Transfer Agreement?

      Upon submission the author will sign the journal’s standard copyright transfer agreement (CTA). The CTA contains text that states that if the article is accepted, and the author chooses the open access option, the author will be required to sign a License to Publish and upload this form to the journal’s manuscript submission system. The article will then be published under the terms of the Creative Commons License Attribution‐Noncommerical No Derivative 4.0 or for articles funded by recognized funding bodies and institutions, under the terms of the Attribution 4.0 (CC BY) license.

    • What is a Creative Commons License?

      Open access articles will be freely available to read, download and share from the time of publication. All open access articles are published under the terms of various Creative Commons 4.0 licenses as defined below:

      • Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): This license is the most restrictive of the six main licenses, only allowing others to download the works and share it with others as long as they credit the original journal and author, but they can’t change the work in any way or use it commercially.
      • Attribution-NonCommerical-ShareAlike (CC BY-NC-SA): This license lets others remix, tweak, and build upon the work noncommercially, as long as they credit the original journal and author and license their new creations under the identical terms.
      • Attribution-NonCommercial (CC BY-NC): This license lets others remix, tweak, and build upon the work noncommercially, and although their new works must also acknowledge the original journal and author and be noncommercial, they don’t have to license their derivative works on the same terms.
      • Attribution-NoDerivs (CC BY-ND): This license allows for redistribution, commercial and noncommercial, of the work as long as it is passed along unchanged and in whole, with credit to the original journal and author.
      • Attribution-ShareAlike (CC BY-SA): This license lets others remix, tweak, and build upon the work even for commercial purposes, as long as they credit the original journal and author and license their new creations under the identical terms. All new works based on the original will carry the same license, so any derivatives will also allow commercial use.
      • Attribution (CC BY): This license lets others distribute, remix, tweak, and build upon the work, even commercially, as long as they credit the journal and author for the original creation. This is the most accommodating of licenses offered.
    • Can Open Access articles be posted to personal website or institutional repositories?

      Yes, the Creative Commons license allows this.

    • Will open access articles be indexed in the same manner as the non‐open access articles in the journal?

      Yes. If an author chooses to publish their accepted article as open access, the article is still a part of the regular journal issue and will be included in the same abstracting and indexing services the journal is covered in regularly.

    • Will open access articles be deposited in PubMedCentral?

      For hybrid open access articles published in journals that are indexed in MEDLINE or who are funded in whole or in part by the National Institutes of Health, the final, published version of the article will be deposited into PubMed Central by Wolters Kluwer.

    • What is the difference between free and open access?

      ‘Free’ is generic, for any content at no cost, like a website, YouTube videos, free abstracts, or articles that are made free for promotion. Though the content is free to read, reuse and sharing is limited by standard copyright and licensing restrictions that applies to all non-open access content. ‘Open access’ content is free permanently on all online locations and allows users to link, read, download, store, use, and data-mine the digital content of that article without copyright or licensing restrictions. The open access licenses (the Creative Commons licenses detailed above) set some restrictions on commercial and derivative uses of open access content.

    • What is the difference between open access and NIH Public Access Policy or funders’ public access policies?

      A number of research funding agencies now require or request authors to submit the post‐print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW identifies to the National Library of Medicine (NLM) articles that require deposit and transmits the post‐print of an article based on research funded in whole or in part by the National Institutes of Health to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism. LWW ensures that authors can fully comply with the public access requirements of major funding bodies worldwide. Additionally, all authors who choose the open access option will have their final published article deposited into PubMed Central provided the journal is indexed by MEDLINE.

    • Does Wolters Kluwer support the recent open access mandates?

      Yes, Wolters Kluwer hybrid open access program provides authors with a means to comply with open access mandates and meet applicable license requirements. Open access articles will be made available under the terms of the Creative Commons License and the final version of the article will be deposited to PubMed Central on publication provided the journal is indexed in MEDLINE or is funded in whole or in part by the National Institutes of Health.

    • My article has already been published; can I make it open access?

      Authors who would like to make their previously published article open access should contact the journal editorial office for more information.

    • Are open access articles published ahead of print?

      Yes, open access articles can be published ahead of print.

    • I have other questions, who can I speak with?

      For any questions, please contact your editorial office or Publisher.

    • What article types may be made open access in journals in the hybrid model?

      In general, only original research including case reports and reviews will be made open access under this option. Please consult the specific journal’s Instruction for Authors for more information.

    • What Wolters Kluwer journals are included in the hybrid model?

      View a list of journals that include the hybrid option.

    • What is an article processing charge?

      The article processing charge (APC) is a payment that allows the article to be freely available online in perpetuity. The costs cover peer‐review, copy‐editing, hosting, and promotion of the article. An APC can be paid for by the funder, author, institution, or a sponsor. Additional page and color charges apply on some hybrid journals. The article processing charges vary for different titles for a variety of factors such as the size of the journal, volume of submissions, etc. View the complete list of APC charges.

    • How do authors pay the article processing charge (APC)?

      Wolters Kluwer will provide authors with a link and instructions on how to pay via our online payment portal.

    • Can institutions or other third parties pay on an author’s behalf?

      Yes, authors can pay by credit card or they can request an invoice to be sent to their institution and third parties. Authors can also forward the payment link we provide to these other parties.

    • How do I know if my institution participates in read-and-publish deals allowing me to request funding for an APC?

      Wolters Kluwer currently has read-and-publish agreements with institutional consortia listed here.

      Corresponding authors who are affiliated with the participating institution and who qualify as eligible authors* can publish their articles open access in the eligible LWW journals at no direct cost to them. To qualify for the APC waiver, the corresponding author must provide their participating institution’s name and institutional email address in the journal’s submission system. On acceptance, the corresponding author will be asked to place an open access order in the publisher’s payment portal where they will be able to request the APC be funded in accordance with this agreement. A $0.00 APC will then be applied.

      Authors can choose to publish under the Creative Commons Attribution License (CC BY) where offered or the Creative Commons Attribution Non-Commercial Non-Derivative License (CC BY-NC-ND).

      *Eligible authors: Corresponding authors who are teaching and research staff employed by or otherwise accredited to one of the participating institutions as well as students enrolled or accredited to one of the institutions and who want to publish open access articles.

    Subscribe to author communications
    Footer Navigation
    • Over ons
    • Nieuws & persberichten
    • Evenementen
    • Oplossingen
    • Gezondheidszorg
    • Fiscaal & Accountancy
    • ESG
    • Financieel
    • Compliance
    • Juridisch
    • Kennis & Expertise
    • Carrières
    • Investeerders
    • Sitemap
    • Website eigenaar
    Follow Wolters Kluwer
    • Facebook
    • Instagram
    • LinkedIn
    • YouTube
    Wolters Kluwer Logo

    When you have to be right

    • Gebruiksvoorwaarden
    • Privacy & Cookies
    • Uw privacykeuzes in Californië
      Your California privacy Choices

    © 2025 Wolters Kluwer N.V. en/of haar dochterondernemingen. Alle rechten voorbehouden.

    Back To Top